The significant outperformance of Axon Enterprise compared to the market, as evidenced by its 41.9% average annual return over 5 years, suggests a strong positive sentiment and operational success. This historical performance, coupled with a substantial market capitalization, indicates a robust financial health and growth trajectory, likely leading to continued investor interest and potentially further gains in the short term.